December 4, 2021 - Virtual Meeting

The UC San Diego Great Debates in Advanced Cutaneous Squamous Cell Carcinoma (CSCC) virtual meeting will provide a multidisciplinary management approach for patients with advanced CSCC. Topics will focus on updates in risk assessment, pathology, medical and surgical management, and radiation therapy. The program will be feature case presentations alongside plenary sessions followed by a question and answer opportunity.

Target Audience

 The target audience includes physicians (in practice and in training) and allied health professionals who care for patients with cutaneous squamous cell carcinoma, including dermatologists, surgical and medical oncologists, otolaryngologists, plastic surgeons, pathologists, and radiation oncologists.

Program Objectives

 Upon completion of this activity, participants should be able to:

  • Define high-risk cutaneous squamous cell carcinoma and the impact on cancer behavior and outcome
  • Describe pathology and molecular characterization of the clinical variants of cutaneous squamous cell carcinoma
  • Examine role of sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma
  • Assess role of radiotherapeutic approaches for advanced cutaneous squamous cell carcinoma
  • Review role of systemic therapy in the treatment of advanced cutaneous squamous cell carcinoma
  • Explore nuances of multidisciplinary management for advanced cutaneous squamous cell carcinoma

Planning Committee

Gregory A. Daniels, MD, PhD
Professor of Medicine
Department of Medicine
Division of Hematology-Oncology
Moores Cancer Center

Soo J. Park, MD
Assistant Professor of Medicine
Department of Medicine
Division of Hematology-Oncology
Moores Cancer Center

Parag Sanghvi, MD, MSPH
Professor of Radiation Medicine and Applied Sciences
Department of Radiation Medicine and Applied Sciences
Clinical Vice Chair
Moores Cancer Center

Full Faculty Listing 

Agenda (as of November 4, 2021) 

​Saturday, December 4, 2021
Welcome and Introduction – Gregory A. Daniels, MD, PhD
8:40am Plenary Session: Identifying CSCC: Where Are We Now With Prognostics?  Chrysalyne D. Schmults, MD, MSCE
Clinical Cases  – David J. Savage, MD, PhD
9:30am Plenary Session: Management of High-Risk CSCC: Nodes, Radiation, and Adjuvant Therapy  Theresa Guo, MD, Parag Sanghvi, MD, MSPH, and Soo J. Park, MD
Cases and Discussion – Kathryn B. Bollin, MD
10:15am Break
Plenary Session: Pathology and Molecular Characterization of CSCC – Brian R. Hinds, MD and Kenneth Y. Tsai, MD, PhD
Question and Answer

Plenary Session: Borderline Resectable CSCC - A Multidisciplinary Discussion – Tjoson Tjoa, MD, Gregory A. Daniels, MD, PhD, and Parag Sanghvi, MD

11:45am Cases and Discussion – Kathryn B. Bollin, MD
12:00pm Break
12:15pm Plenary Session: Intra-tumoral Oncolytic Viroimmunotherapy – Richard G. Vile, PhD
1:15pm Question and Answer
Final Adjournment


  • Physicians: $30
  • Other Learners: $0
  • Virtual Exhibitor: $900
    • Listed on website with hyperlink to vendor website.
    • Acknowledged in final electronic syllabus sent to attendees.
    • 2 complimentary admissions to virtual conference.
    • Live chat with attendees via Zoom room at appointed time. **Vendor to supply zoom link.


Wire Transfers: If you plan to process a wire transfer to cover your registration fee, please email Carissa Aguayo at, to start the process.

Accommodations: For general information or to request reasonable accommodations, contact Bermellyn Imamura at or (858) 822-4770 to submit your request.

Cancellation Policy: The full course tuition is refundable, less $10 if your cancellation is received in writing, on or before November 29, 2021. No refunds will be allowed after this date. In the unlikely event that the course is canceled, UC San Diego Continuing Medical Education is responsible only for a full refund of the registration fee.

green cmeThe program syllabus will be available electronically. The full course syllabus as well as any missing presentations will be available for download on the conference website approximately (1) one week after the conference. UC San Diego Continuing Medical Education (CME) is committed to creating a healthy and sustainable environment.


The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA: The University of California San Diego School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 4.25 hours of Category 1 credit for completing this program.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit™ (report up to 4.25 hours of credit and list "CME Category 1" as the provider number).

Cultural and Linguistic Competency: This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient's primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources can be found on the UC San Diego CME website.

Faculty Disclosure: It is the policy of the University of California San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker's outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.

Follow the Conversation at #ucsdSkinCancer

Show additional content areas below